Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.378
Buy
RSI(14)
70.526
Buy
STOCH(KDJ)(9,3,3)
90.191
Overbought
ATR(14)
2.651
Low Volatility
CCI(14)
105.787
Buy
Williams %R
8.733
Overbought
TRIX(12,20)
0.362
Sell
StochRSI(14)
84.269
Buy
Johnson & Johnson
JNJView Detailed Chart
176.650USD
+1.930+1.10%
Close 08/15, 16:00（ET）Quotes delayed by 15 min
425.16BMarket Cap
19.49P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.10%
5 Days
+2.98%
1 Month
+12.65%
6 Months
+13.13%
Year to Date
+22.15%
1 Year
+11.47%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
27
analysts
BUY
Current Rating
176.650
Target Price
1.10%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
5
Median
8
Average
Company name
Ratings
Analysts
Johnson & Johnson
JNJ
27
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
34
Amgen Inc
AMGN
33
AbbVie Inc
ABBV
28
1
2
3
...
36
Johnson & Johnson Trading Strategy
Medium Term
Short Term
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Buy
Moving Average
Indicators
Value
Direction
MA5
173.814
Buy
MA10
172.030
Buy
MA20
169.479
Buy
MA50
160.849
Buy
MA100
157.876
Buy
MA200
155.967
Buy
News
Trump Plans Major Drug Price Cuts, Pharma Stocks Tumbles
Trump signals an executive order to slash drug prices, causing a sharp sell-off in Asian pharmaceutical stocks. Major companies like Johnson & Johnson, Pfizer, and Abbott could be hit hard.
TradingKeyMon, May 12
.jpg)
Over 60,000 claims filed! Can Johnson & Johnson escape? The judge's stance is unwavering!
Johnson & Johnson (JNJ) is trying to handle claims through a bankruptcy plan. But the judge rejected it. The stock price may continue to decline.
TradingKeyWed, Apr 2
US judge rejects J&J's $10 billion baby powder settlement
NEW YORK, March 31 (Reuters) - A U.S. bankruptcy judge on Monday rejected Johnson & Johnson's JNJ.N $10 billion proposal to end lawsuits alleging that its baby powder and other talc products cause ovarian cancer, marking the third time the company's bankruptcy strategy has failed in court.
ReutersTue, Apr 1
What Are Defensive Stocks? Should You Buy Them Now? Are Defense Stocks Defensive?
TradingKey - Defensive stocks are seen as "safe havens" during economic downturns because their products or services maintain stable demand regardless of economic cycles. Warren Buffett’s investment success is largely attributed to his preference for defensive blue-chip stocks.
TradingKeyFri, Mar 21
Worried About a Recession? 1 Healthcare Dividend Stock That Has Thrived In Every Market Crash
TradingKey - One of those sectors is healthcare and one of the biggest healthcare companies around is Johnson & Johnson (NYSE: JNJ), a company that also pays a decent dividend to shareholders.
TradingKeyFri, Mar 14
Johnson & Johnson Medtech Shockwave Medical Announces U.S. Launch Of Shockwave Javelin Peripheral IVL Catheter
March 4 (Reuters) - Johnson & Johnson JNJ.N:JOHNSON & JOHNSON MEDTECH: SHOCKWAVE MEDICAL ANNOUNCES U.S. LAUNCH OF SHOCKWAVE JAVELIN PERIPHERAL IVL CATHETER
ReutersTue, Mar 4
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Johnson & Johnson is an American multinational corporation specializing in pharmaceuticals, biotechnology, and medical technologies, headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange (NYSE:JNJ). Its common stock is part of the Dow Jones Industrial Average, and the company is ranked No. 42 on the 2024 Fortune 500 list of the largest corporations in the United States. In 2024, it was ranked 45th on the Forbes Global 2000 list. Johnson & Johnson employs approximately 138,000 individuals globally, led by its current chairman and CEO, Joaquin Duato.
Founded in 1886 by three brothers—Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson—the company initially focused on selling ready-to-use sterile surgical dressings. In 2023, the firm spun off its consumer healthcare business segment into a new publicly traded entity, Kenvue, allowing it to concentrate solely on the development and manufacturing of pharmaceutical prescription drugs and medical device technologies.
Johnson & Johnson is recognized as one of the most valuable companies worldwide and is one of only two U.S.-based corporations possessing a prime credit rating of AAA.
Ticker SymbolJNJ
CompanyJohnson & Johnson
CEOMr. Joaquin Boix Duato
Websitehttps://www.jnj.com/
Related Instruments
+2.46%
+0.98%
+0.89%
+1.73%
+1.79%
+2.89%
+2.13%
-0.55%
+0.20%
+1.49%
+0.64%
+1.38%
-0.57%
-0.12%
+0.24%
0.00%
+0.65%
+2.55%
+1.40%
-0.40%
